How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/asymptomatic-left-ventricular-systolic-dysfunction.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Asymptomatic left ventricular systolic dysfunction — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Asymptomatic left ventricular systolic dysfunction (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Asymptomatic left ventricular systolic dysfunction, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Vasotec	ENALAPRILAT	Biovail Labs Intl	enalaprilat	Angiotensin-converting enzyme	1988-01-01
Vasotec	enalapril	Merck & Co.	ACE inhibitor	Angiotensin-converting enzyme, Angiotensin-converting enzyme	1985-12-24
Vasotec	ENALAPRIL MALEATE	Azurity	Angiotensin Converting Enzyme Inhibitor	Angiotensin-converting enzyme	1985-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Azurity · 1 drug in Asymptomatic left ventricular systolic dysfunction
Biovail Labs Intl · 1 drug in Asymptomatic left ventricular systolic dysfunction
Merck & Co. · 1 drug in Asymptomatic left ventricular systolic dysfunction

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Asymptomatic left ventricular systolic dysfunction:

Cite this brief

Drug Landscape (2026). Asymptomatic left ventricular systolic dysfunction — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/asymptomatic-left-ventricular-systolic-dysfunction. Accessed 2026-06-10.

Asymptomatic left ventricular systolic dysfunction full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing